Compounds for the treatment of diabetes or obesity.
CL202601580A1Pending Publication Date: 2026-08-21ELI LILLY & CO
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601580
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-15
- Filing Date
- 2026-05-13
- Publication Date
- 2026-08-21
Abstract
This description relates to novel urocortin-2 polypeptides having activity at corticotropin-releasing hormone receptor 2 (CRHR2), pharmaceutical compositions comprising the polypeptides, and methods of using the polypeptides to treat CRHR2-associated disorders.
Need to check novelty before this filing date? Find Prior Art